- Gastric cancer (GC) is a common and serious condition that affects the stomach lining and has high rates of illness and death, making effective diagnosis and treatment crucial.
- This study evaluated the treatment efficacy and safety of a chemotherapy regimen combining nab-paclitaxel with oxaliplatin and S-1 (P-SOX) compared to the standard SOX regimen in 219 patients with advanced GC over three years.
- The results indicated that the P-SOX regimen provided better short-term and long-term outcomes than SOX, with manageable side effects, suggesting it could become a preferred first-line treatment for GC patients.